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T  cells can discriminate among antigens that differ only slightly in structure 
(1, 2). Direct binding of antigen to T  cells has been difficult to demonstrate (3). 
Antigen recognition by T cells has therefore been indirectly studied by measuring 
activation (i.e., DNA synthesis or cytolytic/inducer function), which occurs only 
after corecognition of antigen and histocompatibility proteins (4-12). To under- 
stand why corecognition is required for T  cell activation, it will be necessary to 
identify physiological binding sites for antigen and histocompatibility proteins, 
and to study their structure and association on the T  cell surface. 
The binding sites of antibodies have been most successfully mapped by using 
hapten-specific antibodies and haptens of systematically varied size and structure 
(13-17). A similar approach may provide structural information about a potential 
T  cell hapten-binding site, if the following requirements are met: (a) clones of 
hapten-reactive T  cells (7-10) are used instead of heterogeneous populations (1, 
2, 4-6);  (b) their recognition of hapten is not materially altered by varying the 
carrier protein to which the hapten is conjugated (8); (c) all structural analogues 
of the hapten  are  recognized in conjunction with the same histocompatibility 
protein  on antigen-presenting cells (APC); l (d) hapten  conjugates that  weakly 
activate or do not activate a clone are immunogenic for other T cells of the same 
strain or haplotype, i.e., lack of activation is not due to inefficient presentation 
by  APC  (10).  Since  all  activating  haptens  must  interact  with  a  physiological 
binding  site  on  the  T  cell  surface,  analysis  of  their  structure  may  suggest 
complementary structural features of the site (1, 2). 
In  this  study,  we describe  inducer T  cell clones specific  for  the p-azoben- 
zenearsonate hapten that possess the properties described above. We have used 
analogues of the arsonate  hapten to identify structural  features important for 
This work was supported by grants AI 13600, CA 26685, and AI 12184, from the National Institutes 
of Health. A. R. is the recipient of a fellowship from the Cancer Research Institute, Inc. and the 
James T. Lee Foundation, New York. Address correspondence to A. R., Laboratory of Immuno- 
pathology, Dana-Farber Cancer Institute, 44 Binney Street, Boston MA 02115. 
I Abbreviations used in this paper:  APC, antigen-presenting cells;  BGG, bovine gamma globulin; 
BSA, bovine serum albumin; CFA, complete Freund's adjuvant; HIS, histidine; IL-2 and -3, interleu- 
kin 2  and 3;  KLH, keyhole limpet hemocyanin; MHC,  major histocompatibility complex; OVA, 
chicken ovalbumin; PBS, phosphate-buffered saline; RGG, rabbit gamma globulin; TYR, tyrosine. 
Structures and abbreviations for arsonate and related haptens are summarized in Table IV. 
j. ExP. MED. © The Rockefeller University Press • 0022-1007/84/02/0479/16  $1.00  479 
Volume 159  February 1984  479-494 480  ACTIVATION SPECIFICITY  OF  ARSONATE-REACTIVE  T  CELL  CLONES 
activation.  In  subsequent  papers, 2'3  we  use  this  information  to  identify  and 
characterize a  cell-surface binding site for arsonate on one of the clones, which 
may function as the physiological receptor for antigen. 
Materials and  Methods 
Mice.  D2.GD  and  BI0.GD  mice  were  generously  provided  by  M.  Dorf,  Harvard 
Medical  School.  B10.A(4R)  mice were bred in  the  animal  facility at  the  Dana-Farber 
Cancer Center. All other mice were obtained from The Jackson Laboratories, Bar Harbor, 
ME and used between 6 wk and 4 mo of age. 
Antigens.  p-Arsanilic, sulphanilic, and p-aminobenzoic acids were obtained from East- 
man Laboratory and Specialty Chemicals, Rochester, NY, and 0-arsanilic  acid, sulphanil- 
amide, p-aminobenzamide and p-nitrobenzenediazonium hexafluorophosphate from Ald- 
rich Chemical Co., Milwaukee, WI. Haptens were conjugated to bovine gamma globulin 
(BGG), ovalbumin (OVA), bovine serum albumin (BSA), and keyhole limpet hemocyanin 
(KLH) using  the  diazonium  salts  (18,  19).  The  isothiocyanate  of p-arsanilic  acid  was 
synthesized using thiophosgene (20) and conjugated to KLH and BSA at 20 mM for 1 h 
at 23°C.  Noncovalently bound haptens were removed by extensive dialysis against phos- 
phate-buffered saline (PBS), pH 7.4. Conjugation ratios for the azo-linked haptens (moles 
hapten)/mole protein) were estimated using an extinction coefficient of 8.15 mM  -t in 0.1 
N NaOH at the isosbestic point of 350 nm (18,  19,  21). The presence of the benzenear- 
sonate hapten on the thiourea-linked conjugated [AR(NCS)] was determined by binding 
to the nonselective class of monoclonal antiarsonate antibodies (see Table VI). Structures 
and abbreviations for all haptens are listed in Table IV. 
Derivation and Culture  of T  Cell Clones.  Arsonate-reactive helper T  cell clones were 
derived from (BALB/c x  A/J) Fl  (CAFI) mice suppressed for production of the cross- 
reactive idiotype (22) (clones Ar-3, Ar-5, Ar-7) or from unsuppressed CAF1 mice (clone 
Ar-4). Conditions for derivation and culture have been described (21,  23).  Clones Ar-3 
and Ar-7 were derived by cloning from a single mass culture; clones Ar-4 and Ar-5 were 
derived independently from two other cultures. 
T  Cell Activation.  Activation  of the  clones  was  measured  as  incorporation  of [3H]- 
4  thymidine by 3-5 x  10  cloned T  cells between 20 and 40 h after stimulation with 5 x 
105 irradiated (2,000 rad) spleen cells and antigen (21, 23). Alternatively, 10  ~ irradiated 
spleen cells were pulsed with 30-50 ~g/ml antigen at 37°C for 1-2 h; excess antigen and 
nonadherent cells were removed by washing and 3-5 x  104 cloned T  cells were added. 
Direct haptenation of splenic APC was performed by treating adherent cells derived from 
10  6 irradiated  spleen cells with  13 mM diazotized arsanilic acid, pH 8.5,  for 20 min at 
room temperature (24). 
Lymph Node Proliferation Assay.  CAFj and D2.GD mice were primed at the base of the 
tail and in the footpads with a total of 100 t~g of S-BSA,  SNH2-BSA, or CONH2-BSA in 
complete Freund's adjuvant (CFA) (7). Inguinal and popliteal lymph nodes were removed 
5  7 d after immunization. Lymph node cells (2-4 x  I0 ) were assayed for DNA synthesis 
on day 4 in response to AR-OVA, S-OVA, SNH~-OVA, or CONH2-OVA. 
Long-term  T  Cell Lines.  Draining  lymph  node  cells  from  CAFt  and  D2.GD  mice 
immunized with S-BSA, SNH2-BSA, or CONH2-BSA as described above were cultured at 
106 cells/ml with 50 #g/ml S-OVA, SNH2-OVA, and CONH2-OVA in Dulbecco's modi- 
fied Eagle's medium containing 0.5%  normal mouse serum, 2  mM glutamine, and 5  x 
10  -5  M  2-mercaptoethanol.  Surviving cells  (enriched  for hapten-reactive T  cells)  were 
tested at day  12 of culture for DNA synthesis in response to AR-OVA, S-OVA, SNH2- 
OVA, or CONH2-OVA presented on syngeneic splenic APC (21, 23). 
Moaoclo~ml Antiarsonate Antibodies.  B cell hybridomas were derived by fusion of immune 
A/J spleen cells (from mice primed and boosted with AR-KLH in CFA) with X63-Ag8.653 
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myeloma cells (25, 26). Culture supernatants of hybridomas and subclones were screened 
for antiarsonate antibodies using a solid-phase radioimmunoassay  (27). Monoclonal anti- 
bodies were purified from ascites fluids (28) by affinity chromatography over individual 
columns of Sepbarose coupled to AR-rabbit gamma globulin (AR-RGG). Binding constants 
of the antibodies for the haptens AR-tyrosine (AR-TYR) and AR-histidine (AR-HIS) were 
determined by quenching of tryptophan fluorescence (29, 30). The content of the cross- 
reactive  idiotype for arsonate (31) was determined in a solution  radioimmunoassay,  by 
measuring the ability of monoclonal antibodies to inhibit the binding of iodinated idiotype- 
positive serum antiarsonate to rabbit anti-idiotype  antibodies (31,  32). Selectivity of the 
antibodies for haptens was monitored in a solid-phase radioimmunoassay  (27). Binding to 
AR-BSA was compared with binding to S-BSA and C-BSA. Similarly, binding to AR-KLH 
and AR(NCS)-KLH  were compared. Antibodies were considered selective if 30-fold or 
more antibody was required to give equivalent binding to the analogues vs. the arsanylated 
proteins (see Fig. 6A), and nonselective  if the ratio was <30-fold (see Fig. 6B). 
Results 
Ge~eration of T Cell Clones.  We derived hapten-reactive helper T  cell clones 
by  immunizing  CAFI  mice  with  AR-KLH,  and  subsequently  stimulating  the 
immune spleen cells with AR-BGG in the absence of exogenous serum proteins 
or growth factors. This protocol selects for survival of arsonate-reactive helper 
T  cells.  T  cells  were  cloned  from  the  enriched  cultures  by limiting  dilution. 
Clones were screened for  DNA synthesis in response to arsonate-coupled  pro- 
teins. 
Characteristics.  All  the  arsonate-responsive  clones  possessed  properties  of 
helper  T  cells:  their  cell  surface  phenotype  was  Thy-l+Ly-l+Ly-2- and  they 
produced  interleukin  2  (IL-2)  and  IL-3  in  response  to  stimulation  (21  and 
unpublished  results).  All  clones  recognized  I  region  major  histocompatibility 
complex (MHC) products; clones Ar-5 and Ar-7 are specific for I-A  d, while clones 
Ar-3  and  Ar-4  recognize  I-A  k.  Clones  specific for  I-E proteins  or  "hybrid"  Ia 
antigens on  Fa cells (33) were not obtained.  Specificity for MHC products was 
established  both  by using  APC  from  inbred  strains  of mice  (Table  I) and  by 
inhibiting  the  response  with  monoclonal  antibodies  specific  for  I-A  and  I-E 
proteins (21). 
Recognition of the Arsonate Hapten.  All the arsonate-reactive clones we obtained 
responded to arsonate coupled to several different carrier proteins but did not 
respond  to  the  carrier  proteins  alone  (Table  II).  However,  there  was  some 
dependence on the protein carrier:  Clone Ar-5 responded to lower concentra- 
tions of AR-OVA than  of AR-BGG, while  the reverse was true  for the  other 
clones tested  (see  Figs.  3  and  4).  All  the  clones also recognized  the  arsonate 
hapten directly conjugated to splenic and tumor APC. The response to directly 
conjugated hapten was MHC-restricted, since it required APC of the appropriate 
haplotype (Table III), and it was inhibited with monoclonal antibodies to appro- 
priate I region proteins (no~t shown). 
Thus arsonate-reactive clones appear to be hapten specific rather than conju- 
gate  specific,  according  to earlier  criteria  (8).  Small  molecules containing  the 
hapten  were not generally immunogenic;  none of the clones were activated by 
AR-HIS (1-300 #M), and only clone Ar-4 responded to AR-TYR (half-maximal 
activation at 3-5 #M AR-TYR).  Like the response to arsanylated proteins,  the 
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TABLE  I 
DNA Synthesis by T Cell Clones in Response to Antigen Presented on 
APC  from Different Strains of Mice 
Strain  I region proteins ex- 
pressed 
[SH]thymidine incorpora- 
tion 
Clone Ar-4  Clone Ar-5 
cp~ 
--  57O  707 
CAF~  I-A  d, I-Ea; I-A  k, I-E  k  122,827  131,201 
A/J  I-A  k, I-E  k  124,802  1,590 
BALB/c  I-A  d, I-E  d  352  143,148 
B10.D2  I-A  d, I-E  d  1,450  78,169 
D2.GD  1-A  d  3,508  108,482 
B10.A  I-A  k, I-E  k  100,273  783 
B10.A(4R)  I-A  k  105,470  ND 
Clones Ar-4 and Ar-5 were incubated with 50 t~g/ml Ar-BGG and irradi- 
ated spleen cells from the indicated  strains of mice. [SH]thymidine incor- 
poration (mean  of duplicates)  was measured between  20 and 40 h after 
stimulation.  The results  are representative  of four similar experiments. 
ND, not done. 
TABLE  II 
DNA Synthesis by T Cell Clones in Response to Arsanylated Proteins 
Presented on Syngeneic APC 
Antigen 
[~H]thymidine incorporation 
Clone At-5  Clone Ar-4 
cpm 
--  1,570  827 
BGG  2,436  552 
AR-BGG  186,096  149,159 
OVA  2,219  696 
AR-OVA  172,672  146,647 
KLH  2,516  1,962 
AR-KLH  184,188  191,793 
Clones Ar-4 and Ar-5 were incubated with irradiated CAFI spleen cells 
and antigen (10-30 #g/ml).  [SH]thymidine incorporation (mean of dupli- 
cates) was measured between  20 and 40 h after stimulation.  The results 
are representative  of three similar experiments. 
Activation by Structurally Related Haptens.  Several  structural  analogues  of the 
arsonate  hapten,  shown  in  Table  IV,  were  conjugated  to carrier  proteins  and 
tested for their ability to activate arsonate-specific  clones. The analogues can be 
grouped  into  two  categories:  (a)  those,  like  the  benzenesulphonate,  benzoate, 
benzenesulphonamide,  benzamide,  and  nitrobenzene  analogues  (S,  C,  SNH~, 
CONH2, and NO2, respectively),  which differ from the arsonate  hapten only in 
the most distal  portion  of the hapten  (Table IV A), and (b) those  derived  from 
diazotized 0-arsanilic acid (OAA) or from the reactive isothiocyanate ofp-arsanilic RAO,  FAAS, AND  CANTOR 
TABLE  III 
DNA Synthesis by Clone Ar-5 in Response to Directly Haptenated 
Splenic APC 
Treatment 
[SH]thymidine  incorporation 
Source of splenic adherent cells 
CAFI  A/J  BALB/c 
cpm 
None  836  770  949 
AR-BGG  99,161  874  61,899 
AR-N,  +  122,924  887  "~,095 
Adherent spleen cells were treated with diazotized arsanilic acid or pulsed 
with AR-BGG (see  Materials and Methods).  [SH]thymidine incorporation 
(mean of triplicates) by 3 ×  104 clone Ar-5 cells was measured between 20 
and  40  h  after  stimulation.  Results  are  representative  of three  similar 
experiments. 
TABLE  IV 
Structural Analogues of the p-Azobenzenearsonate Hapten Used in this Work 
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STRUCTURE  ABBREVIATION  NAME  LINKAGE 
A.  i  _j~--~  O_  OH 
tyr/h  ,-N=N  ~____/ AII~O E)  AR-  Benzenearsonate  p-azo 
.o 
-~--0  0  S-  Benzenesul fonate  p-azo 
,i.0 e  C-  Benzoate  poazo  -C., 0 
0 
-  f-  NH2  SNH ='-  Benzenesul fonami de  p-azo 
-C.//0  CONH~  Benzami de  p-azo 
"NM 2 
/  0  NOz--  N  i t robenzene  p-azo  -N-~ 0 
~  0 H 
<'(~A~ 0 e  OAA-  B  ......  arsonate  o-azo  B.  "  0 
"~-~-'~N::N-  tyr/his 
OH 
lys-N-C-N--~ (  ))-As ~_  ~  -  ~/  u  AR(NCS)- 
s 
Benzenearsonate  thiourea 
acid (AR(NCS)),  which  retain  the  distal  benzenearsonate  moiety but differ in 
their mode of attachment to carrier proteins (Table IVB). 
Activation of one of the arsonate-reactive  clones, Ar-5,  in response to these 
analogues is shown in Fig.  1. The response to AR-BGG was detectable at 0.2 #g/ 
ml and was maximal  at  5-10  #g/ml  (Fig.  1).  C-BGG,  S-BGG, and  SNH~-BGG 
also activated clone Ar-5;  however,  C-BGG was  10-fold less effective while S- 
BGG and SNH2-BGG were 100-300-fold less effective than AR-BGG, as judged 
by the  concentrations  required  to  stimulate  an  equivalent  response.  CONH~- 
BGG,  NO~-BGG,  and  OAA-BGG (Table  IV) did not  stimulate  significant  re- 484  ACTIVATION SPECIFICITY OF  ARSONATE-REACTIVE T  CELL CLONES 
'g 
E 
o= 
o; 
¢ 
"= 
E 
I-- 
3OO 
ZOO 
I00 
CI  AR-BGG 
0  0.2  tO  10 
&C-BGG 
SNH;~-BGG 
S-BGG 
~.,~__~_~_~==~" 
1~  I~0 
Antigen  Cottcentration  (Mg/ml) 
FIGURE  1.  DNA synthesis by clone  Ar-5  in  response  to structural analogues  of arsonate 
conjugated to BGG. [~H]thymidine incorporation by 3 x  104 clone Ar-5 cells was measured in 
response  to irradiated CAFt  spleen cells and antigens  as indicated.  (D) CONH~-BGG, OAA- 
BGG, NO2-BGG, and AR(NCS)-KLH. 
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FIGURE 2.  DNA synthesis by clones Ar-3 and Ar-7  in response  to structural  analogues  of 
arsonate  conjugated to OVA. [aH]thymidine  incorporation by 3 x  10  4 cloned T  cells was 
measured in response to irradiated CAF1 spleen cells and antigens as indicated.  To emphasize 
the cross-reaction  with C-OVA, responses to AR4OVA and C2~OVA  are compared. Haptena- 
tion  ratios  for other conjugates were between  7 and 9 tool of hapten per tool OVA. ([-3) 
CONH2-OVA,  NO~-OVA, OAA-OVA and AR(NCS)-KLH for both clones, and in addition, 
S-OVA and SNHe-OVA for clone Ar-7. 
sponses at concentrations up to 1 mg/ml. Similarly the thiourea-linked conjugate 
AR(NCS)-KLH did not activate clone Ar-5 even at high concentrations (Fig.  1), 
although similarly haptenated  AR-KLH, conjugated via the p-azo group, caused 
detectable  DNA  synthesis  at  1  ug/ml  (see  Table  II).  The  same  results  were 
obtained using OVA conjugates, showing that carrier proteins did not contribute 
significantly to the specificity of activation. 
Two  other  arsonate-reactive  clones  (Ar-3  and  Ar-7)  were  cross-reactively 
activated by p-azobenzoate conjugates (Fig.  2).  To emphasize the cross-reaction, 
Fig. 2  compares responses to highly haptenated C210VA and lightly haptenated RAO,  FAAS,  AND  CANTOR  485 
AR4OVA  (the  subscripts  refer  to  moles  of  hapten  conjugated  per  mole  of 
protein).  Comparison  of  equivalently  haptenated  conjugates  (AR7OVA  with 
CgOVA) showed that -30-100-fold  greater concentration of C-OVA than AR- 
OVA was required to stimulate an equivalent response by the clones (not shown). 
Clone At-3,  like clone At-5,  responded also to high concentrations of S-OVA 
and SNH2-OVA, while clone Ar-7 did not (Fig. 2). 
A  fourth T  cell clone, At-4, had more stringent requirements for activation. 
This clone responded to the arsonate hapten on BGG,  OVA, KLH, and BSA, 
but not to any of the analogues of arsonate conjugated to these carriers (Fig. 3). 
Dependence on Haptenation  Ratio.  The dependence of activation on the hap- 
tenation  ratio  (moles of hapten  conjugated  per  mole protein)  was  examined. 
AR~BGG  and  AR68BGG  elicited  equivalent  responses,  as  did  ARTOVA, 
AR~0OVA, and AR22OVA (the subscripts refer to haptenation ratios) (Fig. 4). 
About 30-100-fold more AR4OVA (or at least 10-fold more in terms of hapten 
concentration) was required in comparison with more highly haptenated OVA 
conjugates to elicit a similar response (Fig. 4B). Although lightly haptenated AR- 
OVA was therefore less effective than expected from its content of hapten, the 
order of effectiveness of AR, S, C, and SNH2 conjugates was unchanged over a 
wide  range  of haptenation  ratios.  Thus  even  AR4OVA  was  somewhat  more 
stimulatory for clones Ar-5, Ar-3 and Ar-7 (two to threefold) than CgIOVA, and 
much more stimulatory for clones Ar-3 and Ar-5 than S16OVA or (SNH2)7 OVA 
(>300-fold)  (Fig.  2).  Quantitative  estimates of the relative effectiveness of the 
different baptens were made using OVA conjugates containing similar amounts 
of hapten. These experiments showed that C-OVA was 30-100-fold less effective 
than  AR-OVA  at stimulating clones Ar-3,  Ar-5,  and  Ar-7,  while S-OVA  and 
SNH2-OVA were between 300-fold and  1,000-fold less effective at stimulating 
clones Ar-3 and Ar-5 (not shown). 
MHC Restriction.  Activation of each  clone by hapten analogues showed the 
same MHC requirement as did activation by arsonate (Table V). Thus, D2.GD 
(or B10.GD)  spleen cells (which express only I-A  d) presented all the activating 
analogues to clones Ar-5 and Ar-7 as effectively as did syngeneic CAF1 spleen 
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FIGURE 3.  DNA synthesis by clone Ar-4 in  response to structural  analogues  of arsonate. 
[SH]thymidine incorporation by 3 x  104 clone At-4 cells was measured in response to irradiated 
CAFI  spleen  cells and  antigens  as  indicated.  (I-I) S,  C,  SHN~,  CONH~,  NO~,  and  OAA 
conjugates of OVA and  BGG, and  AR(NCS)-KLH; the highest response  is shown (<5,000 
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FIGURE 4.  Effect of haptenation ratio on DNA synthesis by clone Ar-5 in response to AR- 
BGG and AR-OVA. [SH]thymidine uptake by  3  x  104  clone Ar-5 cells was  measured in 
response to irradiated CAFI spleen cells and antigens as indicated. (A) AR-BGG, (B) AR-OVA. 
TABLE  V 
DNA Synthesis by T Cell Clones in Response to Haptenated Ovalbumin 
Concen- 
Antigen  tration 
[H]thymidine incorpora- 
tion 
Splenic APC 
A. Clone Ar-5 
pg/ml  cpm 
CAFI  D2.GD 
AR-OVA  1  314,486  294,108 
C-OVA  10  247,732  198,265 
S-OVA  300  294,864  273,727 
SNH~-OVA  1,000  280,612  331,879 
B.  Clone Ar-3 
BIO.A  BI0.A(4R) 
AR-OVA  30  92,145  111,237 
C-OVA  100  90,175  111,469 
S-OVA  1,000  I0,128  I0,894 
SNH~-OVA  1,000  32,275  27,461 
Clones Ar-3 and Ar-5 were incubated with  irradiated spleen cells and 
antigens as indicated. Antigen concentrations were chosen to be at or near 
the  maximal stimulatory concentrations, or were  1 mg/ml if maximal 
stimulation was not attained. [3H]thymidine incorporation (mean of dupli- 
cates) was measured between 20 and 40 h after stimulation. 
cells (Tables  I,  V).  Conversely,  B10.A(4R)  APC,  which  express only I-A  k,  pre- 
sented the activating analogues to  clone  Ar-3 as effectively as did B10.A  APC 
(Table  V).  None  of  the  analogues  activated  a  response  when  presented  by 
inappropriate  APC  (B10.A  for  clones  Ar-5 and  Ar-7;  BI0.D2  for  clones  Ar-3 
and Ar-4; not shown). 
bnmunogenicity of Weakly Activating Conjugates.  Since T  cell activation depends 
on  associative  recognition  of  both  I-A  and  antigen  (11,  12),  we  tested  the RAO,  FAAS,  AND  CANTOR  487 
possibility that nonactivating or weakly activating conjugates such as S, SNH2, 
and CONH2 were poor stimulators because they were not presented by APC in 
correct association with I-A. We showed that this was not the case: primed lymph 
node cells or long-term T  cell lines from CAF] and D2.GD mice immunized with 
S-BSA,  SNH~-BSA, or CONH~-BSA were activated more vigorously by OVA 
conjugates of the immunizing haptens than by arsonate (Fig. 5). 
Monoclonal  Antibodies  to  Arsonate.  We  compared the  patterns  of specificity 
exhibited by cloned T  cells with those exhibited by monoclonai antibodies to 
arsonate. The dissociation constants for AR-TYR and AR-HIS of 15 monoclonal 
antiarsonate antibodies were determined by fluorescence quenching (Table VI), 
and their binding to AR-BSA, S-BSA, and C-BSA was assessed in a solid-phase 
radioimmunoassay (Fig.  6).  Their  content  of the  cross-reactive  idiotype  for 
arsonate  (31)  was  determined in  a  solution  radioimmunoassay (31,  32).  All 
antibodies showed a slight preference for AR-HIS over AR-TYR (generally two 
to fivefold); the preference was striking in  IIIG6, which bound AR-TYR very 
poorly, and  in  VA12,  which did not bind AR-TYR detectably (Table VI).  A 
majority of antibodies  (9/15)  showed a  strong  preference for arsonate  over 
sulphonate and carboxylate (Fig. 6A, Table VI); the remainder (6/15) discrimi- 
nated  only poorly  among  these  three  haptens  (Fig.  6B,  Table  VI).  Binding 
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FIGURE 5.  Response of primed lymph node cells and long-term hapten-reactive T  cell lines 
to the immunizing haptens and arsonate. Draining lymph node cells from D2.GD mice primed 
with S-BSA (A) or CONH~-BSA (B),  and  long-term cell lines derived from draining lymph 
nodes of D2.GD mice primed with SNH2-BSA (C) or CONH2-BSA (D) were assayed for DNA 
synthesis in response  to AR-OVA, S-OVA, SNH2-OVA, or CONH2-OVA as indicated (see 
Materials and Methods). Similar results were obtained using lymph node cells and long-term 
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TABLE  VI 
Characteristics  of  Monoclonal Antibodies to Arsonate 
Antibody  CRI *  Subclass 
K~* 
AR-HIS  AR-TYR 
uM 
Category~ 
IF6  +  IgG1,K  1.1  3.2 
IIIG6  -  IgG1,K  1.2  ! 
IVA8  -  IgG1,K  2.0  8.6 
VAI2  -  IgG2a,~  0.9 
VC7  +  IgG1 ,K  0.6  1.8 
VD2  +  IgG1,K  0.9  2.7 
VD3  Int  IgG1 ,~  0.8  1.9 
VIC1  Int  IgG1,K  1.0  3.0 
IXG5  Int  IgG1 ,~  1.5  4.0 
Selective 
IIC4  -  IgG1,K  0.04  0.1 
VIA3  lnt  IgG2b,x  1.3  4.6 
VIA10  +  IgG2b,~  1.0  1.6 
VIIIG10  +  IgG2b,K  0.9  1.9 
IXE2  +  IgG2b,K  0.7  1.3 
IXE6  +  IgG1 ,K  0.7  2.0 
Nonselective 
* Determined by quenching of tryptophan fluorescence. 
* CR1, cross-reactive idiotype, determined as in refs.  31,  32.  Int, inter- 
mediate, i.e., slope of inhibition curve and maximal inhibition at 2,000 
ng (<60%) in a solution radioimmunoassay for the CRI (31) were both 
less than the corresponding values using purified serum antibodies (see 
32). 
0 Selectivity of the antibodies was monitored by comparing their binding 
to AR-BSA vs. S-BSA and C-BSA, or to AR-KLH vs. AR(NCS)KLH, in 
a  solid-phase radioimmunoassay (Materials and Methods). Selective an- 
tibodies showed a 30-fold or greater preference for conjugates of arson- 
ate vs. its analogues. 
! Low affinity binding that did not saturate in the concentration range 
used (0-30 t~M). 
No detectable binding (K~ >  10  -4 M). 
constants for AR-HIS were ~ 10  -6 M for most antibodies, except IIC4 (4 x  10  -8 
M;  Table  VI).  The  poorly  selective  class  of antibodies  also  bound  well  to 
AR(NCS)KLH, whereas the highly selective class did not (Table VI). 
Discussion 
Early work using heterogeneous hapten-reactive  T  cells showed that  T  cells, 
like antibodies, could discriminate  between related haptens (1,  2,  4-6).  Studies 
with clones of helper and cytolytic T  cells have confirmed this conclusion (7-9). 
The  premise  of our work was that  by using hapten-reactive  T  cell clones and 
hapten  analogues,  the  structural  features of a  hapten  that  were important  for 
activation might be identified.  Further,  the structure and dimensions of hapten 
recognition  sites involved in  T  cell activation  might  be mapped (1,  2) in much 
the  same  way that  binding  sites  of antihapten  antibodies  were  mapped  using 
hapten analogues (13-17). 
We characterize  in  detail  a  small  number  of hapten-specific  inducer  T  cell RAO,  FAAS,  AND  CANTOR  489 
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FIGURE 6.  Selective  binding  by  monoclonal  antibodies  to  arsonate  and  related  haptens. 
Binding of monoclonal antiarsonate antibodies VA 12 and VIA3 to AR-BSA, S-BSA, and C- 
BSA  was  determined  in  a  solid-phase radioimmunoassay  using iodinated,  affinity-purified, 
rabbit anti-mouse antibodies as the developing reagent.  Other monoclonal antibodies were 
tested for selectivity in the same way. 
clones that recognize the p-azobenzenearsonate hapten in any of several contexts, 
i.e., conjugated to different carrier proteins or directly conjugated to I-A-bearing 
APC (Tables II, III; Fig. 4). Such hapten-specific T cells are more easily generated 
to arsonate (9; this study) than to other haptens such as nitrophenyl haptens (7, 
8). We used a series of structural analogues of arsonate (4, 34) to investigate in 
detail  the activation  specificities of these clones.  The analogues  used may be 
grouped into  two series:  In  the  first  the  most distal  portion  of the  hapten  is 
systematically altered,  leaving the azobenzene portion intact; in the second the 
distal benzenearsonate portion is unaltered, but its linkage to carrier proteins is 
changed (Table IV). 
The  clones  provided  examples  of three  different  patterns  of activation  by 
arsonate  and  its  analogues.  Clone  Ar-4  was  completely specific  for  arsonate 
conjugates (Fig. 3). Three of four clones (Ar-3, Ar-5, Ar-7) were also activated 
by p-azobenzoate conjugates, although more weakly, and two of these (Ar-3, Ar- 
5) were activated by p-azobenzenesulphonate and -sulphonamide conjugates as 
well (Figs.  1, 2). Activation by the latter two conjugates was 100-1,000-fold less 
efficient than activation by arsonate (Figs.  1, 2A). 
The order of activation of a clone by arsonate and related conjugates was not 
determined by the  MHC  protein corecognized.  Clone Ar-3,  specific for  I-A  k, 
and  clone  Ar-5,  specific  for  I-A  d,  were  very  similar  in  their  cross-reactive 
responses to C, S, and SNHe conjugates (Figs.  1,  2A). Clone Ar-4, also specific 
for I-A  k, differed from the cross-reactive clone Ar-3 in being highly selective for 
the arsonate hapten (Figs. 2A, 3). Clones Ar-5 and Ar-7, both specific for I-A  d, 
differed (although  less strikingly) in  their activation  specificities (Figs.  1,  2B). 
The results suggest that recognition of arsonate and of MHC proteins by these 
clones can be considered separable properties, at least for experimental purposes. 
By comparing activating and  nonactivating haptens,  the  structural  features 
important for activation may be identified. These include features necessary for 490  ACTIVATION  SPECIFICITY  OF  ARSONATE-REACTIVE  T  CELL  CLONES 
binding, as well as those required to trigger any additional process important for 
activation, such as a conformational change in the receptor. 
Charge.  The negative charge on AR, S, and C conjugates may be important 
for activation. This is most apparent when C  conjugates, which activate clones 
Ar-3,  Ar-5,  and  Ar-7,  are  compared  with  the  structurally  very  similar  but 
uncharged and nonactivating NO2 and CONH2 conjugates (Figs. 1, 2). This may 
indicate that a positively charged group that interacts electrostatically with hapten 
is present in the arsonate-binding site,  as suggested for antibodies to arsonate 
and other negatively charged haptens (41, 42). 
Shape.  The relatively strong cross-reaction between AR and C conjugates for 
three of four clones (Figs.  1, 2) indicates that they are similar in structure as well 
as charge. The benzoate hapten is planar; singly charged benzenearsonate may 
assume a trigonal bipyramidal configuration (43) in which the negative charge is 
distributed between two oxygens coplanar with the benzene ring. The AR hapten 
can make additional interactions, such as a  hydrogen bond involving the axial 
OH group and coordination via a  second axially oriented bond with a group in 
the  binding  site.  Such  additional  interactions  may account  for  the  relatively 
stronger activation of clones Ar-3, Ar-5, and Ar-7 by AR than by C (Figs.  1, 2) 
and for the stringent specificity for arsonate shown by clone Ar-4 (Fig. 3). S and 
SNH2  haptens  may  also  assume  the  trigonal  bipyramidal  configuration  (43); 
alternatively, the amide group of SNH2 may hydrogen bond to the same group 
as the OH group of singly charged arsonate, thus causing the weak cross-reactions 
seen with clones Ar-3 and Ar-5 (Figs.  1, 2). 
Linkage.  The azo-linked benzenearsonate  hapten  (AR) activated all  clones, 
while the thiourea-linked analogue [AR(NCS)] did not (Figs.  1-3). The linkage 
itself (--N~N--  vs. --N--C--N--)  or the amino acid to which the hapten is 
II 
S 
coupled (lysine for  AR(NCS)  vs.  primarily  tyrosine/histidine for  AR)  may be 
recognized. Benzenearsonate linked via an 0-azo group (OAA) did not activate 
the clones (Figs.  1-3).  The OAA hapten is also not recognized by antiarsonate 
antibodies (34, 36), suggesting that the 0-azo group may interfere sterically with 
recognition of the arsonate function. 
For  comparison,  we  examined  the  selectivities of hapten-binding  sites in  a 
panel of 15 monoclonal antiarsonate antibodies derived from A/J mice immu- 
nized with AR-KLH (Fig. 6, Table VI). Some antibodies were strongly selective 
for the arsonate hapten compared with its carboxylate and sulphonate analogues, 
while  others  were  nonselective  (Table  VI).  Both  selective  and  nonselective 
antibodies had similar dissociation constants for AR-TYR and AR-HIS, ~1  ttM 
(Table  VI);  hence the affinity of antiarsonate  antibodies  for arsonate  did  not 
necessarily predict  their selectivities for related  haptens.  In fact,  the antibody 
with highest affinity (IIC4) was nonselective and discriminated poorly between 
AR, S, and C-BSA, while the antibody with lowest affinity (IVA8) was selective 
(Table VI). Similarly, the presence or absence of the cross-reactive idiotypes for 
arsonate (37,  38) does not appear to predict antibody selectivity (Table VI). A 
previous study of monoclonal antibodies to arsonate also showed that selectivity 
did not correlate with affinity for AR-(N-acetyi-TYR) or presence of the cross- RAO,  FAAS,  AND  CANTOR  491 
reactive idiotype; the relative inhibition of antibody binding to AR-BSA by p- 
arsanilic acid versus p-aminobenzoic acid ranged from 4.4-fold (which would be 
considered nonselective by our criteria; see Table VI) to 120-fold (selective) (35). 
Unlike the binding of antibodies  to monovalent haptens in  solution (Table 
VI),  activation  of T  cells  by  APC-bound  antigen  is  not  a  direct  measure  of 
antigen  recognition.  Despite  this  important reservation,  the  concentration  of 
antigen required for half-maximal activation may provide a  crude estimate of 
the strength of interaction  of a  T  cell clone with antigen.  All four arsonate- 
reactive clones  were  half-maximally activated by  equivalent concentrations of 
AR-OVA presented on syngeneic CAFI APC (10-30 #g/ml AR4OVA or 0.3-1 
#g/ml  AR10OVA;  Figs.  2-4  and  unpublished  results);  however,  as  discussed 
above,  their  selectivities  for  related  conjugates are  not  the  same.  Thus,  our 
results suggest that,  as  in  the  case  of antiarsonate  antibodies  (Table  VI),  the 
selectivity of a  T  cell clone and its apparent affinity for arsonate  may not be 
related. 
Our results indicate that some T  cell clones and some antibodies are extremely 
selective for AR compared with S and C, while others are less selective (Figs.  1- 
3, 6). The most selective T  cells show at least the ability of antibodies to make 
fine discriminations between arsonate and its analogues. Certain immunization 
regimens may elicit primarily the selective antibodies (34, 36) or the selective T 
cells (4, 9), while others elicit both classes of response (this study). 
We have examined the participation  of MHC determinants in activation by 
arsonate and its analogues. T  cell activation requires recognition of both antigen 
and MHC determinants (11, 12, 40; Tables I-III), and differences in the response 
to related  antigens  may be  due to changes in the structure  of either  class of 
determinant  (7-10,  12).  However,  since  the  arsonate-reactive  T  cell  clones 
recognize all activating analogues in association with the same MHC protein as 
arsonate  (Table  V),  differences  in  the  corecognized  MHC  protein  are  not 
responsible for differences in activation by the analogues. Moreover, clones with 
completely different MHC specificities, such as Ar-3 and Ar-5, can show similar 
patterns of selectivity (Figs.  1, 2 A). In addition, inefficient presentation by APC 
does not account for the weak activation of arsonate-reactive clones by S-OVA 
and SNH2-OVA, and their lack of activation by CONH2-OVA (Figs. 1-3), since 
primed lymph node cells and long-term hapten-reactive cell lines responded to 
these conjugates more vigorously than to AR-OVA (Fig.  5).  We conclude that 
in  this  system,  where  significant  changes  in  antigen  presentation  and  MHC 
recognition appear unlikely, small alterations in hapten structure can influence 
the level of the response. We therefore postulate a site (or subsite) on arsonate- 
reactive  T  cell  clones  that  interacts  with  hapten  and  may be  experimentally 
separable from the site (or subsite) for MHC determinants. 
Summary 
We describe clones of hapten-specific inducer T  cells from (BALB/c X A/J) F1 
mice that  respond  to  the p-azobenzenearsonate  hapten  conjugated  to  carrier 
proteins or directly conjugated to antigen-presenting cells. Some of the clones 
are  also  activated  by  haptens  structurally  related  to  arsonate.  All  activating 
analogues  are  recognized  by  each  clone  in  association  with  the  same  major 492  ACTIVATION  SPECIFICITY OF  ARSONATE-REACTIVE T  CELL CLONES 
histocompatibility complex (MHC) protein as is arsonate. Weakly activating and 
nonactivating analogues  are  immunogenic  in  D2.GD  and  (BALB/c  x  A/J)FI 
mice, since they can effectively activate primed lymph node cells or long-term 
hapten-reactive cell lines. Hence the specificities of these clones may reflect their 
intrinsic recognition of arsonate and its analogues, rather  than more  efficient 
presentation of certain analogues than of others by antigen-presenting ceils, or 
differential recognition of associated MHC epitopes by the clones. We compare 
the activation specificities of the clones with the binding specificities of monoclo- 
nal antibodies to arsonate, and discuss structural features of the analogues that 
may be important for activation and binding. Our results suggest that a site (or 
subsite) on arsonate-reactive T  cell clones may interact directly with hapten, and 
may be experimentally separable from the site (or subsite) for MHC determinants. 
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